🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae212Source: DataRank Database

Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease is a research paper published in Nephrology Dialysis Transplantation (2024). On theSindex it has a DataRank of 0. It has been cited 46 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access46 citations

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: hybridTopics (12)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Joshua J. Neumiller ORCID,Katherine R. Tuttle ORCID,Radica Z. Alicic ORCID

Live enrichment

PubMed:39907543 PMC:PMC11795665

Bayer AG

hybridLicense: cc-by-nc

publisherhttps://doi.org/10.1093/ndt/gfae212

publisherhttps://academic.oup.com/ndt/article-pdf/40/Supplement_1/i3/61766429/gfae212.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11795665/pdf/gfae212.pdf

Europe_PMChttps://europepmc.org/articles/PMC11795665

Europe_PMChttps://europepmc.org/articles/PMC11795665?pdf=render

MeSH Terms

HumansCardiovascular DiseasesHypoglycemic AgentsPrognosisDrug Therapy, CombinationRenal Insufficiency, ChronicSodium-Glucose Transporter 2 Inhibitors

Keywords

Diabetes mellitusInflammationAlbuminuriacardiovascularCkd